Understanding How Patients and Families Decide on Treatment for New or Recurrent CNS Tumors in Children and Adults

What this Trial Is About

This research aims to explore the factors that influence decision making for patients with new or recurrent central nervous system CNS tumors and their families. The focus is on understanding challenges related to treatment planning and enrolling in clinical trials. The study involves patients of various ages, including children, young adults, and their caregivers, to gather diverse perspectives on these decisions. Participants will take part in qualitative interviews designed to identify specific barriers to treatment and trial enrollment, such as transportation, childcare, and other related expenses. For children 12 years old and younger, only caregivers will be interviewed. Patients aged 13 to 17 may participate along with their caregivers if they choose, while patients 18 years and older can include their caregivers in interviews. The study will assess the impact of community and hospital resources on decision making through follow-up interviews. Throughout the study, participants will engage in interviews that are both structured and open-ended to fully capture their experiences and challenges. Researchers will measure how these resources affect treatment decisions and will identify barriers to trial enrollment within 12 months. The study aims to improve support for patients and families facing CNS tumor treatment decisions, with total participation lasting as needed for follow-up assessments.

CNS Qualitative Interview